Literature DB >> 29887539

Thrombus Formation and Propagation in the Onset of Cardiovascular Events.

Yujiro Asada1, Atsushi Yamashita1, Yuichiro Sato2, Kinta Hatakeyama3.   

Abstract

Ischemic cardiovascular disease is a major cause of morbidity and mortality worldwide and thrombus formation on disrupted atherosclerotic plaques is considered to trigger its onset. Although the activation of platelets and coagulation pathways has been investigated intensively, the mechanisms of thrombus formation on disrupted plaques have not been understood in detail. Platelets are thought to play a central role in the formation of arterial thrombus because of rapid flow conditions; however, thrombus that develops on disrupted plaques consistently includes large amounts of fibrin in addition to aggregated platelets. While, thrombus does not always become large enough to completely occlude the vascular lumen, indicating that the propagation of thrombus is also critical for the onset of cardiovascular events. Various factors, such as vascular wall thrombogenicity, altered blood flow and imbalanced blood hemostasis, modulate thrombus formation and propagation on disrupted plaques. Pathological findings derived from humans and experimental animal models of atherothrombosis have identified important factors that affect thrombus formation and propagation, namely platelets, extrinsic and intrinsic coagulation factors, proinflammatory factors, plaque hypoxia and blood flow alteration. These findings might provide insight into the mechanisms of thrombus formation and propagation on disrupted plaques that lead to the onset of cardiovascular events.

Entities:  

Keywords:  Atherothrombosis; Blood flow; Factor Ⅺ; Platelet; Tissue factor

Mesh:

Year:  2018        PMID: 29887539      PMCID: PMC6099067          DOI: 10.5551/jat.RV17022

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  105 in total

Review 1.  Functional role of protease activated receptors in vascular biology.

Authors:  Maria Adele Alberelli; Erica De Candia
Journal:  Vascul Pharmacol       Date:  2014-06-09       Impact factor: 5.773

2.  Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery.

Authors:  A Yamashita; K Nishihira; T Kitazawa; K Yoshihashi; T Soeda; K Esaki; T Imamura; K Hattori; Y Asada
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

Review 3.  Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

Authors:  A Maino; B Siegerink; L A Lotta; J T B Crawley; S le Cessie; F W G Leebeek; D A Lane; G D O Lowe; F Peyvandi; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2015-07-14       Impact factor: 5.824

4.  C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.

Authors:  Huijun Sun; Tomonari Koike; Tomonaga Ichikawa; Kinta Hatakeyama; Masashi Shiomi; Bo Zhang; Shuji Kitajima; Masatoshi Morimoto; Teruo Watanabe; Yujiro Asada; Yuqing E Chen; Jianglin Fan
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

5.  Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina.

Authors:  M Marzilli; G Sambuceti; S Fedele; A L'Abbate
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

6.  Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events.

Authors:  Meir Preis; Julianna Hirsch; Antonio Kotler; Ahmad Zoabi; Nili Stein; Gad Rennert; Walid Saliba
Journal:  Blood       Date:  2016-12-30       Impact factor: 22.113

Review 7.  The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.

Authors:  Katsuya Hirano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

8.  Expression of tissue factor in the rabbit aorta after balloon injury.

Authors:  K Hatakeyama; Y Asada; K Marutsuka; H Kataoka; Y Sato; A Sumiyoshi
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

9.  Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.

Authors:  Manabu Horii; Shiro Uemura; Masahito Uemura; Masanori Matsumoto; Hiromichi Ishizashi; Keiichi Imagawa; Hajime Iwama; Yukiji Takeda; Hiroyuki Kawata; Tamio Nakajima; Yoshihiro Fujimura; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

Review 10.  The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases.

Authors:  Hajime Abe; Hiroaki Semba; Norihiko Takeda
Journal:  J Atheroscler Thromb       Date:  2017-07-28       Impact factor: 4.928

View more
  13 in total

Review 1.  Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques.

Authors:  Yujiro Asada; Atsushi Yamashita; Yuichiro Sato; Kinta Hatakeyama
Journal:  Pathol Int       Date:  2020-03-13       Impact factor: 2.534

2.  Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.

Authors:  Jingyi Liu; Makoto Nishida; Hiroyasu Inui; Jiuyang Chang; Yinghong Zhu; Kotaro Kanno; Hibiki Matsuda; Masami Sairyo; Takeshi Okada; Hajime Nakaoka; Tohru Ohama; Daisaku Masuda; Masahiro Koseki; Shizuya Yamashita; Yasushi Sakata
Journal:  J Atheroscler Thromb       Date:  2019-03-14       Impact factor: 4.928

3.  Temporal Roles of Platelet and Coagulation Pathways in Collagen- and Tissue Factor-Induced Thrombus Formation.

Authors:  Stefano Navarro; David Stegner; Bernhard Nieswandt; Johan W M Heemskerk; Marijke J E Kuijpers
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 4.  Thrombolytic Enzymes of Microbial Origin: A Review.

Authors:  Deepti Diwan; Zeba Usmani; Minaxi Sharma; James W Nelson; Vijay Kumar Thakur; Graham Christie; Gustavo Molina; Vijai Kumar Gupta
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 6.208

Review 5.  Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy.

Authors:  Farwa Altaf; Shourong Wu; Vivi Kasim
Journal:  Front Mol Biosci       Date:  2021-05-28

Review 6.  Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders.

Authors:  Chaojie Zhu; Junkai Ma; Zhiheng Ji; Jie Shen; Qiwen Wang
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

7.  Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment.

Authors:  Jiezuan Yang; Renyong Guo; Dong Yan; Haifeng Lu; Hua Zhang; Ping Ye; Linfeng Jin; Hongyan Diao; Lanjuan Li
Journal:  Front Cell Infect Microbiol       Date:  2020-07-24       Impact factor: 5.293

Review 8.  Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices.

Authors:  Carlos A Labarrere; Ali E Dabiri; Ghassan S Kassab
Journal:  Front Bioeng Biotechnol       Date:  2020-03-12

9.  Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach.

Authors:  Hui-Yu Li; Hui Sun; Ai-Hua Zhang; Lu-Wen He; Shi Qiu; Jun-Ru Xue; Fangfang Wu; Xi-Jun Wang
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

Review 10.  Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.

Authors:  Hugo Ten Cate; Tomasz J Guzik; John Eikelboom; Henri M H Spronk
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.